News

Ozempic and Wegovy would no longer be covered by the state’s health insurance for low-income people under the governor’s ...
With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...
With President Donald Trump's tariffs wreaking havoc on California’s economy and health costs rising, state leaders will have ...
In fact, you may have gotten more than a few targeted ads on social media from telehealth platforms selling these cheaper GLP ...
A number of celebrities have fled Hollywood for other locales in recent years, and one major star in that group is explaining why they stand behind that decision.
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss the Supreme Court's decision as to the type of ...
Eli Lilly is pumping iron in the GLP-1 prescription ring, gaining muscle with a 52.4% market share and a beefy $1,100 target.